Last, we studied the effect of USP5 genetic alteration on the prognosis of patients in pan-cancer, and the result indicated that patients with USP5 alteration had poor progress-free survival in pan-cancer (Fig. 8F), but not overall survival, disease-free survival and disease-specific survival (Supplementary Fig. 3A–C). Here, USP5 is linked to cancer.